Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Invested Capital (2019 - 2026)

Biodesix filings provide 8 years of Invested Capital readings, the most recent being $9.1 million for Q1 2026.

  • On a quarterly basis, Invested Capital fell 17.43% to $9.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $9.1 million, a 17.43% decrease, with the full-year FY2025 number at -$2.5 million, down 111.81% from a year prior.
  • Invested Capital hit $9.1 million in Q1 2026 for Biodesix, up from -$2.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $42.1 million in Q2 2024 to a low of -$2.5 million in Q4 2025.
  • Median Invested Capital over the past 5 years was $15.8 million (2022), compared with a mean of $15.8 million.
  • Biggest five-year swings in Invested Capital: skyrocketed 456.26% in 2024 and later crashed 111.81% in 2025.
  • Biodesix's Invested Capital stood at $30.9 million in 2022, then dropped by 14.57% to $26.4 million in 2023, then dropped by 21.03% to $20.9 million in 2024, then crashed by 111.81% to -$2.5 million in 2025, then surged by 470.47% to $9.1 million in 2026.
  • The last three reported values for Invested Capital were $9.1 million (Q1 2026), -$2.5 million (Q4 2025), and -$1.7 million (Q3 2025) per Business Quant data.